Search articles by title, topic or section.
Khabre desk
Recent reporting, analysis and explainers from the Health desk.
health
The FDA has authorized Abbott's Libre Duo 10 Day system for people aged 2 years and older with diabetes, allowing continuous glucose and ketone monitoring from a single wearable sensor.
health
The FDA has approved once-daily brepocitinib tablets for adults with dermatomyositis, based on a phase 3 trial that showed better disease-control scores than placebo.
health
Samsung Medison has launched the HERA Z10 premium obstetrics and gynecology ultrasound system, adding AI-assisted workflow and imaging tools to its HERA Z series.
health
WHO has linked new clinical guidance, paediatric formulation priorities and medicine-access work to expand diagnosis and treatment for children and adolescents with sickle cell disease, especially in high-burden countries.
health
NIH researchers identified rare antibodies that blocked human allergic antibodies from binding alpha-gal-containing red-meat allergens in laboratory tests, a finding that could inform future therapies but is not yet a treatment.
health
The European Medicines Agency has opened a voluntary pilot allowing medicine developers to submit data from New Approach Methodologies and receive regulatory feedback on their potential use.
health
EMA's safety committee has started a review of all injectable iron-containing medicines after reports of serious hypophosphataemia and related bone problems, including osteomalacia.
health
The FDA has approved camizestrant with a CDK4/6 inhibitor for selected patients whose HR-positive, HER2-negative advanced breast cancer develops an ESR1 mutation during first-line therapy.
health
The FDA has approved zilganersen for children and adults with Alexander disease, making it the first approved therapy for the rare neurological disorder.
health
New WHO guidance adds an equity lens to national antimicrobial-resistance plans, focusing on water and sanitation, access to health services and essential antibiotics, and surveillance.
health
WHO's second-edition dementia risk-reduction guidelines expand the 2019 recommendations with a life-course approach that includes healthy behaviours, management of health conditions, environmental risks and tailored multidomain interventions.
health
A new WHO systematic review of studies published from 2010 to August 2025 found that the most rigorous evidence does not support a causal association between vaccines, including thiomersal-containing vaccines, and autism spectrum disorder.
health
WHO, Gavi and partner organisations have launched a permanent global mpox vaccine stockpile so countries can obtain outbreak-response doses through an established emergency-allocation mechanism.
health
WHO has invited manufacturers to submit 12 priority childhood cancer medicines for prequalification, including six drugs needing better paediatric formulations and six affected by access or supply problems.
health
WHO has validated Timor-Leste's elimination of trachoma as a public health problem, which means the disease is no longer considered a public-health problem anywhere in WHO's South-East Asia Region.
health
WHO has validated Bhutan as the first country in its South-East Asia Region to eliminate dog-transmitted human rabies as a public health problem, after more than two years without a human death from dog-mediated rabies.
health
WHO has released an updated package of guidance and access measures aimed at improving treatment for children and adolescents with sickle cell disease, especially in sub-Saharan Africa.
health
A Nature study found that late-life semaglutide treatment improved several measures of ageing and extended lifespan in older female mice; whether similar effects occur in humans is unknown.